biblio

Export 6 results:
Filters: Author is Rai, Sunil K.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
S. K. Rai, Allu, S., and Nangia, A. K., Salts and cocrystal of etodolac: advantage of solubility, dissolution, and permeability, Crystal Growth & Design, vol. 20, no. 7, pp. 4512-4522, 2020.
S. K. Rai, Gunnam, A., Mannava, M. K. Chaitan, and Nangia, A. K., Improving the dissolution rate of the anticancer drug dabrafenib, Crystal Growth & Design, vol. 20, no. 2, pp. 1035-1046, 2020.
S. K. Rai, Baidya, D., and Nangia, A. K., Salts, solvates and hydrates of the multi-kinase inhibitor drug pazopanib with hydroxybenzoic acids, Crystengcomm, vol. 23, no. 35, pp. 5994-6011, 2021.
S. K. Rai, Tothadi, S., Arhangelskis, M., George, C. P., Gonnade, R. G., and Nangia, A. K., Polymorph II of hydroxyurea 150 years after its first synthesis, Crystengcomm, vol. 25, no. 18, pp. 2712-2716, 2023.
S. K. Rai, Gunnam, A., Roy, D., Rajput, R., Kulkarni, K., and Nangia, A. K., Cocrystallization of multi-kinase inhibitor pazopanib with fenamic acids: improving dissolution and inhibiting cell migration, CrystEngComm, vol. 25, no. 39, pp. 5565-5574, 2023.
S. K. Rai, Marverti, G., Gunnam, A., Allu, S., and Nangia, A. K., Dabrafenib-panobinostat salt: improving the dissolution rate and inhibition of BRAF melanoma cells, ACS Omega, vol. 8, no. 20, pp. 18255-18265, 2023.